Literature DB >> 12007888

Blood lymphocyte subsets in pigs vaccinated and challenged with Actinobacillus pleuropneumoniae.

G D Appleyard1, S E Furesz, B N Wilkie.   

Abstract

Actinobacillus pleuropneumoniae bacterins do not induce protection in pigs while infection with low doses of the CM5 strain of A. pleuropneumoniae given by aerosol induces complete protection. To evaluate possible correlates of protection in blood lymphocyte subset phenotypes, pigs were treated with a commercial bacterin given intramuscularly, low dose (10(5)cfu/ml) aerosol infection with CM5 or control treatments of the bacterin adjuvant or phosphate buffered saline. All pigs were challenged with a high dose (10(7)cfu/ml) of A. pleuropneumoniae. Lymphocytes and sera were collected prior to and following primary and secondary immunizations and challenge, for evaluation of B- and T-cell markers and antibody to four A. pleuropneumoniae antigens. IgM(micro)+ B-cells were increased following primary exposure to antigen in the bacterin-vaccinated group only. An increase in CD4+ cells in the LD aerosol-infected group was apparent following secondary exposure to antigen. These early changes suggest little difference in lymphocyte populations between treatment groups, however, greater differences were observed following high-dose challenge; CD4+ lymphocytes were increased significantly in both bacterin and LD-challenged groups (p<0.05) while CD8+ cells decreased in the LD-group at this time period. Consequently, there were significant differences (p<0.05) in the CD4:CD8 ratio after high-dose challenge compared to earlier time points and control groups. Variation in cellular expression of SLA-DR and DQ was observed but trends correlating to treatment group were not evident. Complete protection or lack of protection associated with LD challenge or immunisation resulted in significant differences in B-cell frequencies and CD4:CD8 ratio phenotypes in pigs, but only changes in CD4:CD8 ratios appeared relevant to protection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007888     DOI: 10.1016/s0165-2427(02)00002-8

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Protection of piglets by a Haemophilus parasuis ghost vaccine against homologous challenge.

Authors:  Mingming Hu; Yanhe Zhang; Fang Xie; Gang Li; Jianjun Li; Wei Si; Siguo Liu; Shouping Hu; Zhuo Zhang; Nan Shen; Chunlai Wang
Journal:  Clin Vaccine Immunol       Date:  2013-03-27

2.  Association of the porcine cluster of differentiation 4 gene with T lymphocyte subpopulations and its expression in immune tissues.

Authors:  Jingen Xu; Yang Liu; Weixuan Fu; Jiying Wang; Wenwen Wang; Haifei Wang; Jianfeng Liu; Xiangdong Ding; Qin Zhang
Journal:  Asian-Australas J Anim Sci       Date:  2013-04       Impact factor: 2.509

3.  Frequency of Th17 cells correlates with the presence of lung lesions in pigs chronically infected with Actinobacillus pleuropneumoniae.

Authors:  Elena L Sassu; Andrea Ladinig; Stephanie C Talker; Maria Stadler; Christian Knecht; Heiko Stein; Janna Frömbling; Barbara Richter; Joachim Spergser; Monika Ehling-Schulz; Robert Graage; Isabel Hennig-Pauka; Wilhelm Gerner
Journal:  Vet Res       Date:  2017-02-06       Impact factor: 3.683

4.  The FlagT4G Vaccine Confers a Strong and Regulated Immunity and Early Virological Protection against Classical Swine Fever.

Authors:  José Alejandro Bohórquez; Miaomiao Wang; Ivan Díaz; Mònica Alberch; Marta Pérez-Simó; Rosa Rosell; Douglas P Gladue; Manuel V Borca; Llilianne Ganges
Journal:  Viruses       Date:  2022-09-02       Impact factor: 5.818

5.  Low CD4/CD8 ratio in classical swine fever postnatal persistent infection generated at 3 weeks after birth.

Authors:  José Alejandro Bohórquez; Miaomiao Wang; Marta Pérez-Simó; Enric Vidal; Rosa Rosell; Llilianne Ganges
Journal:  Transbound Emerg Dis       Date:  2018-12-09       Impact factor: 5.005

6.  Genomic Analysis of IgG Antibody Response to Common Pathogens in Commercial Sows in Health-Challenged Herds.

Authors:  Leticia P Sanglard; Benny E Mote; Philip Willson; John C S Harding; Graham S Plastow; Jack C M Dekkers; Nick V L Serão
Journal:  Front Genet       Date:  2020-10-23       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.